Binding Sites are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
Binding Sites are considered as similar when the similarity value is greater than 0.44
PDB ID | HET | Uniprot Name | EC Number |
---|---|---|---|
3r1q | X75 | Cyclin-dependent kinase 2 | 2.7.11.22 |
PDB ID | HET | Uniprot Name | EC Number | Binding Site Similarity |
Align |
---|---|---|---|---|---|
3r1q | X75 | Cyclin-dependent kinase 2 | 2.7.11.22 | 1.000 | |
3r6x | X84 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.798 | |
3r28 | XA0 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.785 | |
3roy | 22Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.784 | |
3qwk | X62 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.754 | |
3qwj | X6A | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.701 | |
3qxo | X65 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.666 | |
3rai | X85 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.664 | |
3qu0 | X40 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.659 | |
3r1s | X73 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.655 | |
3rkb | 12Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.653 | |
3rm7 | 19Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.645 | |
3rk9 | 09Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.643 | |
3qx2 | X63 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.640 | |
2r64 | 740 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.638 | |
3r7e | X88 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.631 | |
4ez3 | 0S0 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.630 | |
4erw | STU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.628 | |
3qqf | X07 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.627 | |
3r7v | Z02 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.626 | |
3ddp | RC8 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.624 | |
3qzi | X72 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.622 | |
4lyn | 1YG | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.622 | |
3qzh | X69 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.619 | |
1ke6 | LS2 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.617 | |
1g5s | I17 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.615 | |
3r73 | X87 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.615 | |
3r7i | X9I | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.615 | |
3r8v | Z62 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.615 | |
3rpo | 24Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.614 | |
2duv | 371 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.613 | |
2vtp | LZ9 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.613 | |
3s0o | 50Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.613 | |
3rk7 | 08Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.610 | |
3rm6 | 18Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.609 | |
3r8u | Z31 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.606 | |
4fki | 09K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.606 | |
1ke7 | LS3 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.605 | |
3lfn | A27 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.605 | |
3qzg | X67 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.604 | |
2a0c | CK9 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.603 | |
3s2p | PMU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.601 | |
3sqq | 99Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.600 | |
3r7y | Z04 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.599 | |
3r8l | Z30 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.599 | |
3rk5 | 07Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.598 | |
1w0x | OLO | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.596 | |
3r9h | Z67 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.595 | |
3r83 | Z14 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.594 | |
3r7u | X96 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.593 | |
3rpv | 26Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.593 | |
1oi9 | N20 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.591 | |
2iw9 | 4SP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.591 | |
3qtu | X44 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.591 | |
4eor | 4SP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.591 | |
1v1k | 3FP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.590 | |
2vu3 | LZE | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.590 | |
1h1s | 4SP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.589 | |
2b55 | D31 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.589 | |
2iw6 | QQ2 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.589 | |
3s1h | 56Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.589 | |
4bcm | T7Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.589 | |
2fvd | LIA | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.588 | |
2iw8 | 4SP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.587 | |
1oiy | N41 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.586 | |
3qql | X03 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.586 | |
3rni | 21Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.586 | |
1di8 | DTQ | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.583 | |
3rjc | 06Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.583 | |
1ogu | ST8 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.582 | |
1oit | HDT | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.582 | |
4fkr | 45K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.582 | |
1fvt | 106 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.581 | |
3qrt | X14 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.581 | |
2c6o | 4SP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.580 | |
2w06 | FRV | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.580 | |
1pxk | CK3 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.578 | |
2r3l | SCW | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.578 | |
2w05 | FRT | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.578 | |
3igg | EFQ | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.578 | |
1h1r | 6CP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.577 | |
3ddq | RRC | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.577 | |
3lfq | A28 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.577 | |
1vyz | N5B | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.574 | |
3ig7 | EFP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.574 | |
3r1y | X76 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.574 | |
1ckp | PVB | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.573 | |
2bts | U32 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.573 | |
4ek8 | 16K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.573 | |
1aq1 | STU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.572 | |
2uzo | C62 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.572 | |
3qru | X19 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.572 | |
4bcp | T3C | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.571 | |
3r9d | X6B | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.570 | |
3sw4 | 18K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.570 | |
1vyw | 292 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.568 | |
3ezr | EZR | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.568 | |
3rak | 03Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.568 | |
3qtx | X43 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.567 | |
3qtz | X42 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.567 | |
4fkq | 42K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.567 | |
1ke8 | LS4 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.566 | |
3r71 | X86 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.566 | |
1urw | I1P | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.565 | |
2vtj | LZ4 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.565 | |
1gih | 1PU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.564 | |
2b52 | D42 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.564 | |
3qqk | X02 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.562 | |
2btr | U73 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.561 | |
2uzn | C96 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.561 | |
3ral | 04Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.561 | |
4eok | 4SP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.561 | |
3r8p | Z46 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.560 | |
1pxl | CK4 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.559 | |
3qx4 | X4B | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.559 | |
1h0w | 207 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.558 | |
1ykr | 628 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.558 | |
3le6 | 2BZ | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.558 | |
4bgh | 3I6 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.558 | |
2a4l | RRC | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.557 | |
2xmy | CDK | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.557 | |
3ezv | EZV | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.557 | |
3my5 | RFZ | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.557 | |
1pxm | CK5 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.556 | |
3wbl | PDY | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.556 | |
4bco | T6Q | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.556 | |
1e9h | INR | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.555 | |
1oiq | HDU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.555 | |
4cfn | JYM | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.555 | |
4fkj | 11K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.555 | |
1oir | HDY | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.554 | |
1oiu | N76 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.554 | |
1y91 | CT9 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.553 | |
2r3p | 3SC | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.553 | |
2w1h | L0F | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.552 | |
3ql8 | X01 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.552 | |
1ke5 | LS1 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.551 | |
3fz1 | B98 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.551 | |
3r8z | Z63 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.551 | |
3rmf | 20Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.551 | |
4acm | 7YG | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.551 | |
3qtq | X35 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.550 | |
3unk | 0BY | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.550 | |
1p2a | 5BN | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.549 | |
2vti | LZ3 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.549 | |
2r3k | SCQ | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.548 | |
2c5n | CK8 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.546 | |
2vto | LZ8 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.546 | |
3uli | 1N3 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.546 | |
3qxp | X64 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.545 | |
1ke9 | LS5 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.544 | |
2vtn | LZ7 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.544 | |
4ek6 | 10K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.543 | |
4eos | 1RO | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.542 | |
2i40 | BLZ | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.541 | |
3dog | NNN | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.541 | |
1pxp | CK8 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.540 | |
2bhe | BRY | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.540 | |
4bcq | TJF | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.540 | |
4fkp | LS5 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.540 | |
1h1q | 2A6 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.539 | |
2wpa | 889 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.539 | |
1unl | RRC | Cyclin-dependent-like kinase 5 | 2.7.11.1 | 0.538 | |
2j9m | PY8 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.538 | |
3s00 | Z60 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.538 | |
4kd1 | 1QK | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.537 | |
1w8c | N69 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.536 | |
2r3g | SC9 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.536 | |
1pkd | UCN | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.535 | |
2vv9 | IM9 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.535 | |
1gii | 1PU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.534 | |
2c6t | DT5 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.533 | |
3pxy | JWS | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.533 | |
3qqh | X0A | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.533 | |
4fks | 46K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.533 | |
1r78 | FMD | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.532 | |
2r3i | SCF | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.532 | |
2w17 | I19 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.532 | |
3qtr | X36 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.532 | |
1pxo | CK7 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.531 | |
3lfs | A07 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.530 | |
4eon | 1RO | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.530 | |
2c5y | MTW | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.529 | |
2r3j | SCJ | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.528 | |
2uze | C95 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.528 | |
3sw7 | 19K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.528 | |
2nry | STU | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.527 | |
3pj8 | 404 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.527 | |
4u97 | STU | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.527 | |
1pye | PM1 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.526 | |
2c4g | 514 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.526 | |
2uzb | C75 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.526 | |
2vtq | LZA | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.526 | |
4bcn | T9N | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.526 | |
4fx3 | 60K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.526 | |
1dm2 | HMD | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.525 | |
2x1n | X1N | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.525 | |
3tnw | F18 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.524 | |
2bhh | RYU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.523 | |
4fkt | 48K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.523 | |
1gij | 2PU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.522 | |
3rpy | 27Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.522 | |
1xjd | STU | Protein kinase C theta type | 2.7.11.13 | 0.521 | |
2exm | ZIP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.521 | |
2wxv | WXV | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.521 | |
3py0 | SU9 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.521 | |
3v5l | 0G1 | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.521 | |
1b38 | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.520 | |
1h1p | CMG | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.520 | |
2r3r | 6SC | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.520 | |
4fkw | 62K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.520 | |
2xnb | Y8L | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.519 | |
3o0g | 3O0 | Cyclin-dependent-like kinase 5 | 2.7.11.1 | 0.519 | |
4fkg | 4CK | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.519 | |
4fkv | 61K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.519 | |
2vts | LZC | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.518 | |
3mfs | ANP | Peripheral plasma membrane protein CASK | 2.7.11.1 | 0.517 | |
2c6l | DT4 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.516 | |
3she | I85 | MAP kinase-activated protein kinase 3 | 2.7.11.1 | 0.516 | |
4kio | G5K | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.516 | |
2cch | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.515 | |
2uzl | C94 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.515 | |
2vth | LZ2 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.515 | |
1b39 | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.513 | |
2bkz | SBC | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.513 | |
2r3m | SCX | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.513 | |
2wip | P49 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.513 | |
3r9n | Z68 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.513 | |
3rah | O1Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.512 | |
4fko | 20K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.512 | |
3unj | 0BX | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.511 | |
1e1x | NW1 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.510 | |
2phk | ATP | Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform | 2.7.11.19 | 0.510 | |
3bht | MFR | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.510 | |
2wih | P48 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.508 | |
3tiz | 3TI | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.508 | |
4eol | 1RO | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.508 | |
2c6k | DT2 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.507 | |
1h0v | UN4 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.506 | |
1nvs | UCM | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.504 | |
2c6m | DT5 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.504 | |
3rpr | 25Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.504 | |
4ogr | ADN | Cyclin-dependent kinase 9 | 2.7.11.22 | 0.504 | |
2b53 | D23 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.502 | |
2f2c | AP9 | Cyclin-dependent kinase 6 | 2.7.11.22 | 0.502 | |
4gih | 0X5 | Non-receptor tyrosine-protein kinase TYK2 | 2.7.10.2 | 0.502 | |
4qmp | DKI | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.502 | |
1y8y | CT7 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.501 | |
4eoi | 1RO | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.501 | |
2b54 | D05 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.500 | |
4fv5 | EK9 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.500 | |
2pvn | P63 | Casein kinase II subunit alpha | 2.7.11.1 | 0.499 | |
1fvv | 107 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.498 | |
1v0p | PVB | Cell division control protein 2 homolog | 2.7.11.22 | 0.498 | |
3ti1 | B49 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.498 | |
3v8t | 477 | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.498 | |
4fv4 | EK7 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.498 | |
2vtt | LZD | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.497 | |
1fin | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.496 | |
2uzd | C85 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.496 | |
2wot | ZZG | TGF-beta receptor type-1 | 2.7.11.30 | 0.496 | |
4aoj | V4Z | High affinity nerve growth factor receptor | 2.7.10.1 | 0.496 | |
4eom | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.496 | |
2c6i | DT1 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.494 | |
3fzr | 3JZ | Protein-tyrosine kinase 2-beta | 2.7.10.2 | 0.494 | |
3nup | 3NU | Cyclin-dependent kinase 6 | 2.7.11.22 | 0.494 | |
4nj3 | 2KD | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.494 | |
3lq5 | SLQ | Cyclin-dependent kinase 9 | 2.7.11.22 | 0.493 | |
2ds1 | 1CD | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.492 | |
3rzb | 02Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.492 | |
3say | OFT | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.492 | |
4fkl | CK2 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.492 | |
4l7s | G7K | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.492 | |
4oac | ADP | Protein BRASSINOSTEROID INSENSITIVE 1 | 2.7.10.1 | 0.492 | |
1v0o | INR | Cell division control protein 2 homolog | 2.7.11.22 | 0.491 | |
2vuw | 5ID | Serine/threonine-protein kinase haspin | 2.7.11.1 | 0.491 | |
4c61 | LMM | Tyrosine-protein kinase JAK2 | / | 0.491 | |
4fv9 | E71 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.491 | |
4oa9 | ANP | Protein BRASSINOSTEROID INSENSITIVE 1 | 2.7.10.1 | 0.491 | |
2csn | CKI | Casein kinase I homolog 1 | 2.7.11.1 | 0.489 | |
4i0s | 1B5 | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.489 | |
2izr | BRK | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.488 | |
2izs | BRQ | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.488 | |
2euf | LQQ | Cyclin-dependent kinase 6 | 2.7.11.22 | 0.487 | |
2pvl | P55 | Casein kinase II subunit alpha | 2.7.11.1 | 0.487 | |
3mtf | A3F | Activin receptor type-1 | 2.7.11.30 | 0.487 | |
2r3o | 2SC | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.486 | |
4u9a | STU | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.486 | |
2nru | T12 | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.485 | |
2vtl | LZ5 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.485 | |
3qtw | X3A | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.485 | |
4bch | T7Z | Cyclin-dependent kinase 9 | 2.7.11.22 | 0.484 | |
4bgg | 844 | Activin receptor type-1 | 2.7.11.30 | 0.484 | |
4ftu | 7HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.484 | |
1qmz | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.483 | |
2c69 | CT8 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.483 | |
3be9 | P04 | Casein kinase II subunit alpha | 2.7.11.1 | 0.483 | |
4ez5 | 0RS | Cyclin-dependent kinase 6 | 2.7.11.22 | 0.483 | |
4jqe | ANP | Casein kinase II subunit alpha | 2.7.11.1 | 0.483 | |
2xb7 | GUI | ALK tyrosine kinase receptor | 2.7.10.1 | 0.482 | |
3i60 | E86 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.482 | |
3nux | 3NV | Cyclin-dependent kinase 6 | 2.7.11.22 | 0.482 | |
2r3f | SC8 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.481 | |
2ym6 | YM6 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.481 | |
3r9o | Z71 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.481 | |
3tki | S25 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.481 | |
4g6o | E28 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.480 | |
2y7j | B49 | Phosphorylase b kinase gamma catalytic chain, liver/testis isoform | 2.7.11.19 | 0.479 | |
3ggf | GVD | Serine/threonine-protein kinase 26 | / | 0.479 | |
3nyn | SGV | G protein-coupled receptor kinase 6 | 2.7.11.16 | 0.479 | |
5e8w | STU | TGF-beta receptor type-1 | 2.7.11.30 | 0.479 | |
3wi6 | YRZ | MAP kinase-activated protein kinase 2 | 2.7.11.1 | 0.478 | |
5ack | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.478 | |
4feq | 0T8 | Tyrosine-protein kinase receptor TYRO3 | 2.7.10.1 | 0.477 | |
1e1v | CMG | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.476 | |
4ii5 | ADP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.476 | |
5cvh | ADP | Casein kinase II subunit alpha | 2.7.11.1 | 0.476 | |
1gy3 | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.475 | |
4fv6 | E57 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.475 | |
4gfo | 0X2 | Non-receptor tyrosine-protein kinase TYK2 | 2.7.10.2 | 0.475 | |
5aab | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.475 | |
1qcf | PP1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.474 | |
1u59 | STU | Tyrosine-protein kinase ZAP-70 | 2.7.10.2 | 0.474 | |
3hrc | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.474 | |
3q9y | TXQ | Casein kinase II subunit alpha | 2.7.11.1 | 0.474 | |
3qzf | X66 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.474 | |
3vs7 | KS1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.474 | |
4ivb | 1J5 | Tyrosine-protein kinase JAK1 | / | 0.474 | |
4krc | AGS | Cyclin-dependent protein kinase PHO85 | 2.7.11.22 | 0.474 | |
3nuu | JOZ | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.473 | |
4bkz | 1WS | Maternal embryonic leucine zipper kinase | 2.7.11.1 | 0.473 | |
4fob | 0US | ALK tyrosine kinase receptor | 2.7.10.1 | 0.473 | |
4l3j | 5FI | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.473 | |
5aac | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.473 | |
2pvh | P19 | Casein kinase II subunit alpha | 2.7.11.1 | 0.472 | |
2qkr | IXM | Cdc2-like CDK2/CDC28 like protein kinase | / | 0.472 | |
4gub | 0Y4 | Casein kinase II subunit alpha | 2.7.11.1 | 0.472 | |
4hyh | 1AM | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.472 | |
2i0y | 5CN | Macrophage colony-stimulating factor 1 receptor | 2.7.10.1 | 0.471 | |
2wms | ZYS | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.471 | |
3r2b | 05B | MAP kinase-activated protein kinase 2 | 2.7.11.1 | 0.471 | |
3uyt | 0CK | Casein kinase I isoform delta | 2.7.11.1 | 0.471 | |
4a06 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.471 | |
4gmy | 0X5 | Tyrosine-protein kinase JAK2 | / | 0.471 | |
4i3z | ADP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.471 | |
4oh4 | ANP | Protein BRASSINOSTEROID INSENSITIVE 1 | 2.7.10.1 | 0.471 | |
4qmx | H8H | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.471 | |
5dr6 | SKE | Aurora kinase A | 2.7.11.1 | 0.471 | |
1gz8 | MBP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.470 | |
2br1 | PFP | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.470 | |
2vz6 | FEF | Calcium/calmodulin-dependent protein kinase type II subunit alpha | 2.7.11.17 | 0.470 | |
3et7 | 349 | Protein-tyrosine kinase 2-beta | 2.7.10.2 | 0.470 | |
4ks8 | B49 | Serine/threonine-protein kinase PAK 6 | 2.7.11.1 | 0.470 | |
4q5j | ANP | Protein BRASSINOSTEROID INSENSITIVE 1 | 2.7.10.1 | 0.470 | |
1sm2 | STU | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.469 | |
2hxl | 422 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.469 | |
2ym4 | 4YM | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.469 | |
3v8w | 0G2 | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.469 | |
4dgn | LU2 | Casein kinase II subunit alpha | 2.7.11.1 | 0.469 | |
1nvq | UCN | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.468 | |
2h8h | H8H | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.468 | |
2h96 | 893 | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.468 | |
2j0m | 4ST | Focal adhesion kinase 1 | 2.7.10.2 | 0.468 | |
3bhh | 5CP | Calcium/calmodulin-dependent protein kinase type II subunit beta | 2.7.11.17 | 0.468 | |
3llt | ANP | Protein serine/threonine kinase-1 | / | 0.468 | |
4fv8 | E63 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.468 | |
4hge | 15V | Tyrosine-protein kinase JAK2 | / | 0.468 | |
1phk | ATP | Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform | 2.7.11.19 | 0.467 | |
2r3q | 5SC | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.467 | |
2yex | YEX | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.467 | |
3mfr | ANP | Peripheral plasma membrane protein CASK | 2.7.11.1 | 0.467 | |
3mfu | ANP | Peripheral plasma membrane protein CASK | 2.7.11.1 | 0.467 | |
4c62 | XWW | Tyrosine-protein kinase JAK2 | / | 0.467 | |
4gk3 | L87 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.467 | |
2wou | ZZF | TGF-beta receptor type-1 | 2.7.11.30 | 0.466 | |
3qyw | 6PB | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.466 | |
4anm | WUL | Casein kinase II subunit alpha | 2.7.11.1 | 0.466 | |
4b99 | R4L | Mitogen-activated protein kinase 7 | 2.7.11.24 | 0.466 | |
4gk2 | L66 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.466 | |
1lp4 | ANP | Casein kinase II subunit alpha | 2.7.11.1 | 0.465 | |
4bie | IE6 | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.465 | |
4eop | 1RO | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.465 | |
4i22 | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.465 | |
4rqv | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.465 | |
4xx9 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.465 | |
1vjy | 460 | TGF-beta receptor type-1 | 2.7.11.30 | 0.464 | |
2b9j | ADP | Mitogen-activated protein kinase FUS3 | 2.7.11.24 | 0.464 | |
2zv2 | 609 | Calcium/calmodulin-dependent protein kinase kinase 2 | 2.7.11.17 | 0.464 | |
3hzt | J60 | Calmodulin-like domain protein kinase isoform 3 | / | 0.464 | |
4ftr | 5HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.464 | |
5aaa | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.464 | |
1e7v | LY2 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.463 | |
2brm | DFZ | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.463 | |
2xp2 | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.463 | |
3a60 | STU | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.463 | |
3t8o | ATP | Rhodopsin kinase | / | 0.463 | |
4agu | D15 | Cyclin-dependent kinase-like 1 | / | 0.463 | |
4cki | ADN | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.463 | |
4foc | 0UU | ALK tyrosine kinase receptor | 2.7.10.1 | 0.463 | |
1eh4 | IC1 | Casein kinase I homolog 1 | 2.7.11.1 | 0.462 | |
1nvr | STU | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.462 | |
1ny3 | ADP | MAP kinase-activated protein kinase 2 | 2.7.11.1 | 0.462 | |
3c0g | 3AM | Peripheral plasma membrane protein CASK | 2.7.11.1 | 0.462 | |
3u4u | LNH | Casein kinase II subunit alpha | 2.7.11.1 | 0.462 | |
4c02 | TAK | Activin receptor type-1 | 2.7.11.30 | 0.462 | |
4gj2 | 0XH | Non-receptor tyrosine-protein kinase TYK2 | 2.7.10.2 | 0.462 | |
5ani | ES4 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.462 | |
2e9n | 76A | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.461 | |
2vag | V25 | Dual specificity protein kinase CLK1 | 2.7.12.1 | 0.461 | |
3fzs | B96 | Protein-tyrosine kinase 2-beta | 2.7.10.2 | 0.461 | |
3oro | AGS | Serine/threonine protein kinase | / | 0.461 | |
3qcy | 3Q3 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.461 | |
4ivd | 15T | Tyrosine-protein kinase JAK1 | / | 0.461 | |
4rqk | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.461 | |
2vtr | LZB | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.460 | |
2zdt | 46C | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.460 | |
3qts | X46 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.460 | |
4fux | E75 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.460 | |
1jst | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.459 | |
1ung | ALH | Cyclin-dependent-like kinase 5 | 2.7.11.1 | 0.459 | |
2b9i | ADP | Mitogen-activated protein kinase FUS3 | 2.7.11.24 | 0.459 | |
2e9u | A25 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.459 | |
3i4b | Z48 | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.459 | |
3i5z | Z48 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.459 | |
3qcs | 3Q1 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.459 | |
3zh8 | C58 | Protein kinase C iota type | 2.7.11.13 | 0.459 | |
1m2r | MNY | Casein kinase II subunit alpha | 2.7.11.1 | 0.458 | |
2brg | DFY | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.458 | |
2brn | DF1 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.458 | |
2oji | 33A | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.458 | |
2r5t | ANP | Serine/threonine-protein kinase Sgk1 | 2.7.11.1 | 0.458 | |
3cbl | STU | Tyrosine-protein kinase Fes/Fps | 2.7.10.2 | 0.458 | |
3f7z | 34O | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.458 | |
3uim | ANP | BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 | 2.7.10.1 | 0.458 | |
4eoo | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.458 | |
1unh | IXM | Cyclin-dependent-like kinase 5 | 2.7.11.1 | 0.457 | |
1uv5 | BRW | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.457 | |
3i81 | EBI | Insulin-like growth factor 1 receptor | 2.7.10.1 | 0.457 | |
3mdv | CL6 | Cholesterol 24-hydroxylase | / | 0.457 | |
4anq | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.457 | |
4c3f | 7KW | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.457 | |
4ct1 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.457 | |
4gfg | 0XF | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.457 | |
5dt0 | SKE | Aurora kinase A | 2.7.11.1 | 0.457 | |
1ad5 | ANP | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.456 | |
1om1 | IQA | Casein kinase II subunit alpha | 2.7.11.1 | 0.456 | |
1zys | 199 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.456 | |
2np8 | CC3 | Aurora kinase A | 2.7.11.1 | 0.456 | |
2y9q | ANP | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.456 | |
2zjw | REF | Casein kinase II subunit alpha | 2.7.11.1 | 0.456 | |
3hmm | 855 | TGF-beta receptor type-1 | 2.7.11.30 | 0.456 | |
3mtl | FEF | Cyclin-dependent kinase 16 | 2.7.11.22 | 0.456 | |
4acc | 7YG | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.456 | |
4au8 | Z3R | Cyclin-dependent-like kinase 5 | 2.7.11.1 | 0.456 | |
4dgm | AGI | Casein kinase II subunit alpha | 2.7.11.1 | 0.456 | |
4eny | J19 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.456 | |
4erk | OLO | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.456 | |
4h1j | 0YH | Protein-tyrosine kinase 2-beta | 2.7.10.2 | 0.456 | |
4yuq | KS1 | Calmodulin-like domain protein kinase | / | 0.456 | |
5dr9 | SKE | Aurora kinase A | 2.7.11.1 | 0.456 | |
1uu7 | BI2 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.455 | |
2bro | DF2 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.455 | |
3ckx | STU | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.455 | |
4e20 | 0MY | Non-receptor tyrosine-protein kinase TYK2 | 2.7.10.2 | 0.455 | |
4fsz | HK8 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.455 | |
4ft5 | H2K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.455 | |
4qmt | H1N | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.455 | |
4yzc | STU | Serine/threonine-protein kinase/endoribonuclease IRE1 | 2.7.11.1 | 0.455 | |
1q41 | IXM | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.454 | |
2hy0 | 306 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.454 | |
3ag9 | A02 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.454 | |
3c4x | ATP | Rhodopsin kinase | / | 0.454 | |
3cd3 | STU | Tyrosine-protein kinase Fes/Fps | 2.7.10.2 | 0.454 | |
3qcq | 3Q0 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.454 | |
3qd3 | 3Q5 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.454 | |
4aw0 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.454 | |
4riy | ADP | Epidermal growth factor receptor | 2.7.10.1 | 0.454 | |
5e8x | STU | TGF-beta receptor type-1 | 2.7.11.30 | 0.454 | |
2cgw | 3C3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.453 | |
2x8i | X8I | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.453 | |
3eb0 | DRK | Uncharacterized protein | / | 0.453 | |
3zmm | F9J | Tyrosine-protein kinase JAK2 | / | 0.453 | |
4fsw | HK6 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.453 | |
4g6n | EK0 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.453 | |
4ic7 | ANP | Mitogen-activated protein kinase 7 | 2.7.11.24 | 0.453 | |
4jr7 | GNP | Casein kinase II subunit alpha | 2.7.11.1 | 0.453 | |
1snu | STU | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.452 | |
1tqp | ATP | RIO-type serine/threonine-protein kinase Rio2 | 2.7.11.1 | 0.452 | |
2bdf | 24A | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.452 | |
2e9v | 85A | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.452 | |
2x8e | X8E | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.452 | |
3amb | VX6 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.452 | |
3we4 | 5FI | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.452 | |
3zlx | 5EZ | Dual specificity mitogen-activated protein kinase kinase 1 | 2.7.12.2 | 0.452 | |
4enx | Z20 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.452 | |
4fv3 | EK6 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.452 | |
4mf1 | 29Y | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.452 | |
5drd | ATP | Aurora kinase A | 2.7.11.1 | 0.452 | |
5e8y | STU | TGF-beta receptor type-2 | 2.7.11.30 | 0.452 | |
3vry | B43 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.451 | |
4bf2 | STU | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.451 | |
4fv0 | EK3 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.451 | |
4hgs | 15G | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.451 | |
4mq2 | 2C4 | Dual specificity tyrosine-phosphorylation-regulated kinase 1A | 2.7.12.1 | 0.451 | |
2ydi | YDI | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.450 | |
3c4z | ADP | Rhodopsin kinase | / | 0.450 | |
3vrz | VRZ | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.450 | |
3wow | ANP | Casein kinase II subunit alpha | 2.7.11.1 | 0.450 | |
4dgo | 0JW | Casein kinase II subunit alpha | 2.7.11.1 | 0.450 | |
4ei4 | 0Q2 | Tyrosine-protein kinase JAK1 | / | 0.450 | |
4hvi | 19S | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.450 | |
1byg | STU | Tyrosine-protein kinase CSK | / | 0.449 | |
1py5 | PY1 | TGF-beta receptor type-1 | 2.7.11.30 | 0.449 | |
2pml | ANP | Uncharacterized protein | / | 0.449 | |
3elj | GS7 | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.449 | |
3kga | LX9 | MAP kinase-activated protein kinase 2 | 2.7.11.1 | 0.449 | |
4btj | ATP | Tau-tubulin kinase 1 | 2.7.11.1 | 0.449 | |
4fv2 | EK5 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.449 | |
4gii | 0X6 | Non-receptor tyrosine-protein kinase TYK2 | 2.7.10.2 | 0.449 | |
4k18 | 1OB | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.449 | |
4qbj | NHM | Glycylpeptide N-tetradecanoyltransferase | 2.3.1.97 | 0.449 | |
5ajq | DB8 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.449 | |
1q5k | TMU | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.448 | |
1u54 | ACP | Activated CDC42 kinase 1 | / | 0.448 | |
1uu3 | LY4 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.448 | |
2clq | STU | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.448 | |
2om9 | AJA | Peroxisome proliferator-activated receptor gamma | / | 0.448 | |
2xch | CKG | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.448 | |
3at3 | ATK | Casein kinase II subunit alpha | 2.7.11.1 | 0.448 | |
3v5j | 0F2 | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.448 | |
4ft7 | H3K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.448 | |
4gj3 | 0XP | Non-receptor tyrosine-protein kinase TYK2 | 2.7.10.2 | 0.448 | |
4m87 | NAD | Enoyl-[acyl-carrier-protein] reductase [NADH] | / | 0.448 | |
4wbo | ANW | Rhodopsin kinase | / | 0.448 | |
1ir3 | ANP | Insulin receptor | 2.7.10.1 | 0.447 | |
2c3l | IDZ | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.447 | |
2j0j | 4ST | Focal adhesion kinase 1 | 2.7.10.2 | 0.447 | |
2wmt | ZYT | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.447 | |
3q3b | 55E | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.447 | |
4c4j | X21 | Dual specificity protein kinase TTK | 2.7.12.1 | 0.447 | |
4dym | IYZ | Activin receptor type-1 | 2.7.11.30 | 0.447 | |
4fmq | ANP | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.447 | |
4fsn | A58 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.447 | |
4fsr | HKC | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.447 | |
4h3p | ANP | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.447 | |
4ix6 | ADP | Uncharacterized protein | / | 0.447 | |
4kb8 | 1QN | Casein kinase I isoform delta | 2.7.11.1 | 0.447 | |
1wvx | BD4 | Death-associated protein kinase 1 | 2.7.11.1 | 0.446 | |
2c3k | ABO | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.446 | |
2xa4 | AZ5 | Tyrosine-protein kinase JAK2 | / | 0.446 | |
3a99 | ANP | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.446 | |
4anu | EM7 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.446 | |
4ivc | 1J6 | Tyrosine-protein kinase JAK1 | / | 0.446 | |
4kik | KSA | Inhibitor of nuclear factor kappa-B kinase subunit beta | 2.7.11.10 | 0.446 | |
4mq1 | 2C3 | Dual specificity tyrosine-phosphorylation-regulated kinase 1A | 2.7.12.1 | 0.446 | |
2pe1 | 517 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.445 | |
3bkb | STU | Tyrosine-protein kinase Fes/Fps | 2.7.10.2 | 0.445 | |
3hll | I45 | Mitogen-activated protein kinase 14 | / | 0.445 | |
3lcd | BDY | Macrophage colony-stimulating factor 1 receptor | 2.7.10.1 | 0.445 | |
3niz | ADP | Cdc2-like CDK2/CDC28 like protein kinase | / | 0.445 | |
3ofm | 4B0 | Casein kinase II subunit alpha' | 2.7.11.1 | 0.445 | |
3owk | 18E | Casein kinase II subunit alpha | 2.7.11.1 | 0.445 | |
3w55 | 1FM | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.445 | |
4flh | 14K | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.445 | |
4fod | 0UV | ALK tyrosine kinase receptor | 2.7.10.1 | 0.445 | |
4nmb | FAD | Bifunctional protein PutA | / | 0.445 | |
4rrv | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.445 | |
4zse | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.445 | |
1csn | ATP | Casein kinase I homolog 1 | 2.7.11.1 | 0.444 | |
1pxj | CK2 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.444 | |
2r0u | M54 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.444 | |
3ama | SKE | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.444 | |
3orm | AGS | Serine/threonine protein kinase | / | 0.444 | |
4ach | KDI | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.444 | |
4ccu | AWF | ALK tyrosine kinase receptor | 2.7.10.1 | 0.444 | |
4e4m | 0NH | Tyrosine-protein kinase JAK2 | / | 0.444 | |
4fsy | HK7 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.444 | |
4oj4 | DIF | Peroxisome proliferator-activated receptor gamma | / | 0.444 | |
5csh | ATP | Casein kinase II subunit alpha | 2.7.11.1 | 0.444 | |
1yi3 | LY2 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.443 | |
2brb | PFQ | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.443 | |
2dq7 | STU | Tyrosine-protein kinase Fyn | 2.7.10.2 | 0.443 | |
2gcd | STU | Serine/threonine-protein kinase TAO2 | 2.7.11.1 | 0.443 | |
2hog | 710 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.443 | |
2ieb | ZID | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.443 | |
2wtc | VGM | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.443 | |
2xyu | Q9G | Ephrin type-A receptor 4 | 2.7.10.1 | 0.443 | |
3rvg | 17P | Tyrosine-protein kinase JAK2 | / | 0.443 | |
3u9n | 09H | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.443 | |
3zdi | UGJ | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.443 | |
4aua | 4AU | Cyclin-dependent kinase 6 | 2.7.11.22 | 0.443 | |
4aw1 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.443 | |
4ewh | T77 | Activated CDC42 kinase 1 | / | 0.443 | |
4j03 | FVS | Bifunctional epoxide hydrolase 2 | 3.1.3.76 | 0.443 | |
4l52 | 1UL | Mitogen-activated protein kinase kinase kinase 7 | 2.7.11.25 | 0.443 | |
1m2q | MNX | Casein kinase II subunit alpha | 2.7.11.1 | 0.442 | |
1mru | AGS | Serine/threonine-protein kinase PknB | 2.7.11.1 | 0.442 | |
2xck | MH4 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.442 | |
2xik | J60 | Serine/threonine-protein kinase 25 | 2.7.11.1 | 0.442 | |
2yfx | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.442 | |
3blr | CPB | Cyclin-dependent kinase 9 | 2.7.11.22 | 0.442 | |
3l8p | 0CE | Angiopoietin-1 receptor | 2.7.10.1 | 0.442 | |
3lct | ADP | ALK tyrosine kinase receptor | 2.7.10.1 | 0.442 | |
3lpb | NVB | Tyrosine-protein kinase JAK2 | / | 0.442 | |
4bib | IEO | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.442 | |
4e93 | GUI | Tyrosine-protein kinase Fes/Fps | 2.7.10.2 | 0.442 | |
4fny | I3K | ALK tyrosine kinase receptor | 2.7.10.1 | 0.442 | |
4fv1 | EK4 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.442 | |
4g17 | 0VN | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.442 | |
4grb | 0XG | Casein kinase II subunit alpha | 2.7.11.1 | 0.442 | |
4iwd | 1JC | Hepatocyte growth factor receptor | 2.7.10.1 | 0.442 | |
2cgv | 3B3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.441 | |
2e9o | A58 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.441 | |
2fum | MIX | Serine/threonine-protein kinase PknB | 2.7.11.1 | 0.441 | |
2pe2 | 464 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.441 | |
3f69 | XDR | Serine/threonine-protein kinase PknB | 2.7.11.1 | 0.441 | |
3hdm | MMG | Serine/threonine-protein kinase Sgk1 | 2.7.11.1 | 0.441 | |
3vs6 | VSH | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.441 | |
4anw | O92 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.441 | |
4anx | 534 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.441 | |
4b8l | A0P | Aurora kinase B-A | 2.7.11.1 | 0.441 | |
4ft0 | HK9 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.441 | |
4g2f | C07 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.441 | |
4iva | 1J5 | Tyrosine-protein kinase JAK2 | / | 0.441 | |
1daw | ANP | Casein kinase II subunit alpha | 2.7.11.1 | 0.440 | |
1zz2 | B11 | Mitogen-activated protein kinase 14 | / | 0.440 | |
3emg | 685 | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.440 | |
3nuy | JPZ | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.440 | |
4ans | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.440 | |
4ftt | 6HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.440 | |
4h4u | NDP | Biphenyl dioxygenase ferredoxin reductase subunit | / | 0.440 | |
4hvh | 19R | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.440 | |
4q73 | FAD | Bifunctional protein PutA | / | 0.440 |